The Texas Alzheimer’s Research and Care Consortium (TARCC) is a collaboration between ten of the state’s leading medical research institutions, working to improve early diagnosis, treatment, and prevention of Alzheimer’s disease.
1 in 9 people age 65+ has Alzheimer's disease.
About 490,000 Texans are projected to have Alzheimer's by 2025.
Every 66 seconds, someone in the United States develops Alzheimer’s.
TARCC Research Updates
TARCC investigators have been involved in a number of new, important research studies. Recently published research is wide ranging, spanning the gamut from clinical trials to new cognitive diagnostics; blood-based biomarkers in Mexican-Americans; identification of additional risk genes; and validation of biomarker algorithms in AD patients and AD animal models.
Read TARCC's Latest Facebook Posts:
Join us today for the TARCC Scientific Symposium starting soon! Click the link to view the live stream for our keynote speaker @ 8:30 am Dr. Sterling Johnson Ph.D, & two presenters Dr. Sudha Seshadri MD @ 10:00 am, & Gladys Maestre MD, Ph.D @11:30 am! conta.cc/3woiKhQ